AzTrials
AzTrials

Muscle Protein SynthesisICADPNCT03303729

Influence of Carbohydrate on Amino Acid Absorption From Dietary Protein (ICADP)

A study testing Meat Hydrolysate and Cluster Dextrin in people with Muscle Protein Synthesis and Amino Acid, run by Bispebjerg Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

10 young males will be recruited to participate in a randomized double blinded crossover study to investigate the influence of concomitant intake of two different types of carbohydrate with protein hydrolysate on the absorption kinetics of protein-derived amino acids and the impact on myofibrillar protein synthesis. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Muscle Protein Synthesis, Amino Acid
What is being tested?
Meat Hydrolysate and Cluster Dextrin
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
1 siteDenmark
Study dates
24 Nov 2017to 23 Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • young healthy adults,
  • organised sport/training 1-3 times per week

Who cannot join

  • Subject younger than 18 years or above 30 years
  • BMI > 30
  • Chronic medical diseases: active cancer, renal diseases, metabolic diseases like diabetes mellitus.
  • Physical inactivity. Subjects must participate in systematized weekly exercise 1-3 times per week.
  • Participating in systematized exercise more than 3 times per week.
  • Vegetarian.
  • Participating in a special diet which deviates from the standard of young adults.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Bispebjerg Hospital

    Copenhagen, Copenhagen NV, 2400

Other trials in Denmark

About this study

Official title: Influence of Carbohydrate on Amino Acid Absorption From Dietary Protein

10 young males will be recruited to participate in a randomized double blinded crossover study to investigate the influence of concomitant intake of two different types of carbohydrate with protein hydrolysate on the absorption kinetics of protein-derived amino acids and the impact on myofibrillar protein synthesis. During the trial days the subjects will perform a bout of whole body resistance exercise and ingest a supplement of meat hydrolysate labeled with D5-phenylalanine together with randomized and double blinded type of carbohydrate consisting of either glucose or cluster dextrin.

The primary outcome is the time to obtain peak concentration of D5-phenylalanine after intake of meat hydrolysate with either glucose or cluster dextrin.

Read more

Hypotheses:

  1. The cluster dextrin will increase the absorption of the amino acids from the meat hydrolysate, and thereby result in a faster rise and a higher peak in plasma amino acid concentration in the postprandial period.

II) The meat hydrolysate will increase the protein synthesis rate to a higher extent when combined with cluster dextrin than with glucose.

Being tested
Meat Hydrolysate, Cluster Dextrin, Placebo
Keywords
Carbohydrate, Cluster Dextrin, Exercise training, Protein supplement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Meat HydrolysateDietary supplement

    25 grams of meat hydrolysate to maximally stimulate protein synthesis.

  • Cluster DextrinDietary supplement

    Also called CAS no.: 9050-36-6, Glico Nutrition Co., Ltd.

    75 grams of Cluster Dextrin

  • PlaceboDietary supplement

    Also called Glucose

    75 grams of Glucose

Study groups in NCT03303729
Study groupRoleWhat they receive
Meat hydrolysate & Cluster DextrinExperimentalMeat hydrolysate containing 25g of protein given together with 75 grams of Cluster Dextrin.
Receives: Dietary Supplement: Meat Hydrolysate; Dietary Supplement: Cluster Dextrin
Meat hydrolysate & placeboActive comparatorMeat hydrolysate containing 25g of protein given together with 75 grams of Glucose.
Receives: Dietary Supplement: Meat Hydrolysate; Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Protein hydrolysate amino acid label time to peak appearance in plasma

    Difference between the time to peak of protein-derived D5-phenylalanine amino acid appearance in the plasma

    Measured: From hour 0 to hour 3

Secondary outcomes (3)
  1. Myofibrillar protein fractional synthesis rate response to protein and carbohydrate intake after a whole body resistance exercise

    Difference between myofibrillar protein fractional synthesis rate after meat hydrolysate with either 75 grams of Cluster Dextrin or Clucose.

    Measured: from hour 0,5 to hour hour 1. From hour 1 to hour 3. From hour 0,5 to hour 3.

  2. Protein hydrolysate amino acid label area under the concentration curve in plasma

    Difference between the area under the concentration curve of protein-derived D5-phenylalanine amino acid appearance in the plasma

    Measured: From hour 0 to hour 3

  3. Insulin concentration

    Difference between insulin concentrations after intake of the two carbohydrate types.

    Measured: From hour 0 to hour 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2017
  2. Study start24 Nov 2017
  3. Primary completion23 Feb 2018
  4. Study completion23 Feb 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03303729
Sponsor's protocol ID
H-17017363
Acronym
ICADP
Status last verified
Feb 2018
First submitted
3 Oct 2017
Last updated
27 Feb 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Nishimura Y, Jensen M, Bulow J, Thomsen TT, Arimitsu T, van Hall G, Fujita S, Holm L. Co-ingestion of cluster dextrin carbohydrate does not increase exogenous protein-derived amino acid release or myofibrillar protein synthesis following a whole-body resistance exercise in moderately trained younger males: a double-blinded randomized controlled crossover trial. Eur J Nutr. 2022 Aug;61(5):2475-2491. doi: 10.1007/s00394-021-02782-y. Epub 2022 Feb 19.

    PubMed 35182194

Questions about this trial

What is this clinical trial studying?

A study testing Meat Hydrolysate and Cluster Dextrin in people with Muscle Protein Synthesis and Amino Acid, run by Bispebjerg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Protein hydrolysate amino acid label time to peak appearance in plasma (time frame: From hour 0 to hour 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03303729, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in